Folke Sjöqvist - Curriculum vitae#
Obituary, Karolinska Insitutet
Obituary, EACPT
Obituary, Medicinska Föreningen
Curriculum vitae#
Academic background
- 1959 Swedish MD (license to practice medicine).
- 1962 Swedish PhD in basic pharmacology, both at the Karolinska Institutet, Stockholm, Sweden.
- 1958-1963 (periodically) training in clinical medicine, mainly in internal medicine and primary health care.
- 1962-1963 Acting associate professor in basic pharmacology, Karolinska Institutet and consultant in clinical pharmacology to the Royal Swedish Medical Board of Health.
- 1963-1965 Training in clinical pharmacology in USA at the National Heart Institute, NIH, Bethesda and Dept. of Medicine, The Johns Hopkins School of Medicine, Baltimore.
- 1970 Nominated for the first chair in clinical pharmacology in Scandinavia.
Positions in Sweden
- 1970-1999 Professor and head physician in clinical pharmacology at the University of Linköping (1970-1972) and the Karolinska Institutet (1972-1999).
- 1972-1999 Member of the Nobel Assembly and Nobel Committee in Medicine. Member of the Swedish Drug Board, chairman of the Swedish Committee on Adverse Drug Reactions.
- 1980-1987 Member of the board of Karolinska Institutet. Chairman of the curriculum committee for medical students, Karolinska Institutet.
- 1987-1997 Chief physician/research director at Huddinge University Hospital.
- 1997 Professor emeritus in clinical pharmacology at Karolinska Institutet.
International positions
- 1979-1980 Special assistant to the director of the National Institute of General Medical Sciences, Bethesda, USA.
- 1982-2006 Honorary doctor degrees at Universities in France, Finland, Estonia, England, and Denmark.
- 1993-1999 Director, WHO Collaborating Center on Drug Utilization, Research and Clinical Pharmacological Services, Huddinge University Hospital. Expert to WHO, Geneva in clinical pharmacology.
- 1995-2000 Chairman European Association for Clinical Pharmacology and Therapeutics (EACPT).
- 2010 Chairman of the scientific liaison group between IUPHAR and WHO.